Showing results (1-10 of 745) with videos related to
Sort By:
Pageof 75
A&A Practice|January 12, 2026
Enhanced Ventilation Strategies in Bariatric Surgery: A Case Report of Flow-Controlled Ventilation in an Extremely Obese Patient Undergoing Robot-Assisted Bariatric SurgeryDavid Sohm, Marcus J Schultz, Timur YurttasBritish Journal of Anaesthesia|June 1, 2026
Flow-controlled ventilation: general settings and compliance-guided positive end-expiratory pressure and driving pressure titrationsTimur Yurttas, Franziska Wagner, Julien Fessler, et al.A&A Practice|April 14, 2026
Flow Controlled as Compared to Pressure-Controlled Ventilation for One-Lung Ventilation During Thoracic SurgeryJoel Hanselmann, Franziska Wagner, Marcus J Schultz, et al.Journal of Clinical Medicine|February 5, 2020
Biomarker-Based Preoperative Risk Stratification for Patients Undergoing Non-Cardiac SurgeryTimur Yurttas, Reka Hidvegi, Miodrag FilipovicCurrent Opinion in Anaesthesiology|May 17, 2017
Perioperative management of antithrombotic therapiesTimur Yurttas, Patrick M Wanner, Miodrag FilipovicBritish Journal of Anaesthesia|May 14, 2023
Analgesic efficacy of systemic lidocaine using lean body mass based dosing regime versus placebo in bariatric surgery: a prospective, randomised, double-blind, placebo-controlled, single-centre studyTimur Yurttas, Mirjana Djurdjevic, Thomas W Schnider, et al.Anesthesiology Clinics|May 2, 2026
Closed Claims Analysis of Data for Ambulatory AnesthesiaEmma Reichegger, Timur Yurttas, Markus M Luedi, et al.The Journal of Antimicrobial Chemotherapy|June 11, 2004
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosisMarcus J SchultzMedical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 30, 2008
Lung-protective mechanical ventilation with lower tidal volumes in patients not suffering from acute lung injury: a review of clinical studiesMarcus J SchultzCurrent Drug Targets|June 26, 2004
Is surfactant a promising additive drug in ALI/ARDS-patients?Marcus J Schultz, Jozef KeseciogluPageof 75